Cargando…

Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy

This is a data article from the original publication “Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy” [1]. From January 2014 to April 2019 a sample collective of 785 patients with 3T multiparametric magnetic resonance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klingebiel, M, Arsov, C, Ullrich, T, Quentin, M, Al-Monajjed, R, Mally, D, Sawicki, LM, Hiester, A, Esposito, I, Albers, P, Antoch, G, Schimmöller, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Data Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679720/ https://www.ncbi.nlm.nih.gov/pubmed/36426072 http://dx.doi.org/10.1016/j.dib.2022.108683

Ejemplares similares

Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins
por: Quentin, M., et al.
Publicado: (2022)

Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
por: Ullrich, T., et al.
Publicado: (2020)

Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
por: Valentin, B., et al.
Publicado: (2021)

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
por: Boschheidgen, M., et al.
Publicado: (2022)

MRI grading for the prediction of prostate cancer aggressiveness
por: Boschheidgen, M., et al.
Publicado: (2021)

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization
por: Boschheidgen, Matthias, et al.
Publicado: (2023)

Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection
por: Ziayee, Farid, et al.
Publicado: (2021)

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
por: Osses, Daniël F., et al.
Publicado: (2020)

Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body (68) Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?
por: Morawitz, Janna, et al.
Publicado: (2022)

Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer
por: Venderink, Wulphert, et al.
Publicado: (2017)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
por: Benelli, Andrea, et al.
Publicado: (2020)

Surgical treatment of metastatic germ cell cancer
por: Hiester, Andreas, et al.
Publicado: (2021)

Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy
por: Zhou, Yi, et al.
Publicado: (2018)

An annotated test-retest collection of prostate multiparametric MRI
por: Fedorov, Andriy, et al.
Publicado: (2018)

Dataset of prostate MRI annotated for anatomical zones and cancer
por: Adams, Lisa C., et al.
Publicado: (2022)

Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided
por: Rothwax, Jason T., et al.
Publicado: (2014)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2015)

Multiparametric magnetic resonance imaging-targeted biopsies in the detection of clinically significant prostate cancer
por: Charalampos, Fragkoulis
Publicado: (2020)

Magnetic Resonance Imaging-Guided Prostate Biopsy: Present and Future
por: Kim, Chan Kyo
Publicado: (2015)

Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels
por: Bang, Seokhwan, et al.
Publicado: (2021)

MRI Screening and MRI/US Fusion-Guided Transperineal Biopsy in Detecting Prostate Cancer
por: Yin, Hongqing, et al.
Publicado: (2021)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
por: Bruckmann, Nils Martin, et al.
Publicado: (2021)

Evaluation of a robotic technique for transrectal MRI-guided prostate biopsies
por: Schouten, Martijn G., et al.
Publicado: (2011)

How to Improve TRUS-Guided Target Biopsy following Prostate MRI
por: Park, Byung Kwan
Publicado: (2021)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

A prospective study of magnetic resonance imaging and ultrasonography (MRI/US)-fusion targeted biopsy and concurrent systematic transperineal biopsy with the average of 18-cores to detect clinically significant prostate cancer
por: Hakozaki, Yuji, et al.
Publicado: (2017)

The urologist’s learning curve of “in-bore” magnetic resonance-guided prostate biopsy
por: Rosenzweig, Barak, et al.
Publicado: (2021)

Magnetic resonance imaging-guided prostate biopsy—A review of literature
por: Seetharam Bhat, Kulthe Ramesh, et al.
Publicado: (2021)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Concordance of MRI-Guided Fusion and Systematic 12-Core Prostate Biopsy for the Detection of Prostate Cancer
por: Parsons, Matthew, et al.
Publicado: (2022)

MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions
por: Abd Ali, Furat, et al.
Publicado: (2023)

Patients’ experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study
por: Pizzoli, Silvia Francesca Maria, et al.
Publicado: (2020)

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men
por: Peltier, Alexandre, et al.
Publicado: (2015)

Intra-Individual Comparison of Physiologic [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis
por: Novruzov, Emil, et al.
Publicado: (2023)

STHLM3-MRI study: Role of magnetic resonance imaging-targeted biopsy in prostate cancer screening
por: Gaur, Abhay S.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vb2op8vi9cp5c4nvi7k7s5aj32